Cas:148-83-4 6-[(2E)-3,7-dimethylocta-2,6-dienyl]-7-hydroxychromen-2-one manufacturer & supplier

Chemical Name:6-[(2E)-3,7-dimethylocta-2,6-dienyl]-7-hydroxychromen-2-one

CAS.NO:148-83-4

Synonyms:6-(3,7-dimethyl-octa-2,6-dienyl)-7-hydroxy-chromen-2-one;Ostruthine;6-(3,7-Dimethyl-octa-2,6-dienyl)-7-hydroxy-cumarin;6-(3,7-Dimethyl-2,6-octadienyl)-7-hydroxycoumarin;6-Geranyl-7-hydroxycoumarin;Ostruthin;EINECS 207-581-1;6-(3,7-dimethyl-octa-2,6-dienyl)-7-hydroxy-coumarin

Molecular Formula:C₁₉H₂₂O₃

Molecular Weight:298.37600

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:485.3ºC at 760 mmHg

Density:1.116 g/cm3

Index of Refraction:1.573

PSA:50.44000

Exact Mass:298.15700

LogP:4.73380

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6-(3,7-dimethyl-octa-2,6-dienyl)-7-hydroxy-chromen-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-(3,7-dimethyl-octa-2,6-dienyl)-7-hydroxy-coumarin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 207-581-1 Use and application,EINECS 207-581-1 technical grade,usp/ep/jp grade.

Related News: RELATED: CVS, Walgreens begin rolling out over-the-counter COVID tests from Abbott, Ellume and more 6-[(2E)-3,7-dimethylocta-2,6-dienyl]-7-hydroxychromen-2-one manufacturer Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical. 6-[(2E)-3,7-dimethylocta-2,6-dienyl]-7-hydroxychromen-2-one supplier Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical. 6-[(2E)-3,7-dimethylocta-2,6-dienyl]-7-hydroxychromen-2-one vendor In these situations, the API is not a single substance but the culmination of various ingredients. 6-[(2E)-3,7-dimethylocta-2,6-dienyl]-7-hydroxychromen-2-one factory In these situations, the API is not a single substance but the culmination of various ingredients.